New PET agent could be a versatile clot catcher

German researchers have shown that a new small-molecule radiotracer can work with PET, and PET alone, to image blood clots in multiple anatomic regions and regardless of where they formed.

Their preclinical study is running in the July edition of the Journal of Nuclear Medicine and is nicely summarized in a news item posted by SNMMI’s communications department.

“Currently available diagnostic techniques of thrombus [blood clot] imaging rely on different modalities depending on the vascular territory,” study co-author Andrew Stephens, MD, PhD, of Piramal Imaging GmbH in Germany says in the item.

SNMMI says the new, fast-clearing tracer—18F-GP1—ably detected small venous and arterial clots, plus endothelial damage and emboli in the brain, in a primate trial.

Click here to read the full study and below for the SNMMI news item.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.